RxDoctor Payments Data

Charity Hightree, PA

Physician Assistant · Springfield, MONPI 1053046383

Payments from drug & device makers

$4,115in general payments, 2019–2025

Across 97 payments — averaging $42.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Novartis$309
  • Boehringer Ingelheim$223
  • Abbott$194
  • E.r. Squibb & Sons, L.L.C.$180
  • Impulse Dynamics (USA) Inc.$157
  • plus $606 from 7 others

What the payments were for

  • Travel & lodging$1,39034%
  • Food & beverage$2,68065%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,115 in reported general payments places this provider in the 90th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$36,976
Medicare patients
399
Services billed
745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban182$169,262
EntrestoSacubitril/Valsartan64$61,556
JardianceEmpagliflozin58$61,121
XareltoRivaroxaban49$50,089
Propafenone Hcl27$2,078
Flecainide Acetate38$1,698
Midodrine Hcl25$1,689
Mexiletine Hcl12$1,522
Dofetilide20$1,496
Metoprolol Succinate165$1,096
Dabigatran EtexilateDabigatran Etexilate Mesylate14$1,023
Amiodarone Hcl47$908
Digoxin41$841
Amlodipine Besylate74$556
Diltiazem 24hr Er (Cd)Diltiazem Hcl19$508

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$309$61,55664 claims
Boehringer IngelheimJardiance$223$61,12158 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →